AC_Hamilton1 Profile Banner
Ashleigh Russell Profile
Ashleigh Russell

@AC_Hamilton1

Followers
203
Following
387
Media
14
Statuses
60

Clinical Lecturer in Medical Oncology @CPH_QUB. Views and opinions my own.

Belfast, Northern Ireland
Joined December 2018
Don't wanna be here? Send us removal request.
@AC_Hamilton1
Ashleigh Russell
2 months
Excellent day at the RCSI with patients, caregivers, researchers and charities discussing the landscape of bowel cancer in Ireland - both moving and motivating to drive progress. @RCSI_Irl
0
2
7
@AC_Hamilton1
Ashleigh Russell
1 year
Delighted to share results on exploring the experiences of early-onset colorectal cancer patients. Key findings: - there is a lack of recognition for EOCRC patients. - areas of unmet need include information needs, mental health, sexual health and fertility counselling.
@HelenColemanQUB
Prof Helen Coleman
1 year
*NOW ONLINE* one of the most important papers we’ve published @AC_Hamilton1 @DrHelenReid @OlindaSantin Understanding the treatment experiences of early-onset bowel cancer patients Qualitative research interviewing 21 patients with lived experience https://t.co/dZrOMUbWnW
0
3
14
@CRUK_Policy
Cancer Research UK Policy
2 years
🚨New @CRUK_Policy report🚨 We've just published the full findings from our 2023 Survey of the Clinical Research Workforce. Conducted to inform our #CancerManifesto, it describes the issues that matter most to researchers across the UK. Full paper 👇 https://t.co/b4EWdJdo5g
1
16
30
@acmedsci
Academy of Medical Sciences
2 years
Together with @The_MRC, we are asking medically qualified professionals to share their thoughts on barriers to progression in clinical academia in the UK. Share your thoughts through the survey below 👇
@The_MRC
Medical Research Council
2 years
We're running a survey to gather insights on the challenges and barriers to progression in UK clinical academia. If you're a medically qualified professional with experience in clinical academia, we'd like to hear from you. Complete the survey➡️ https://t.co/7VUvmAZS5p
2
32
27
@DeborahAlsina
Deborah Alsina
2 years
New study funded by @CR_UK highlights rising incidence & deaths due to bowel cancer in under 50s. @bowelcanceruk's #NeverTooYoung campaign was launched in 2013 to highlight this. The work continues. A great source of information & support. https://t.co/MauBwbp8HS
Tweet card summary image
theguardian.com
Experts say alarming projections stem from surge in obesity, poor diets and physical inactivity
0
4
4
@AC_Hamilton1
Ashleigh Russell
2 years
Would highly recommend this conference for Clinical Academics in the UK and Ireland - come and join us in Belfast this year!
@acmedsci
Academy of Medical Sciences
2 years
Registration is now open to attend our Clinical Academics in Training Annual Conference 📣 Hear inspiring presentations and meet others working in biomedical and health research 🔬 📆 17 April 2024 📍 Belfast Free to attend - register now: https://t.co/Cew2jbgcYH
0
2
7
@gwalls89
Gerard Walls
2 years
Open minded about a career in Oncology? Join us in the NI Cancer Centre for an Open Evening on Monday! Hear about a day in the life of an Oncologist, as well the range of opps this rewarding career can provide (featuring🍕) Virtual registration also possible – see below!
1
14
28
@NICanReg
NI Cancer Registry
2 years
*BREAKING NEWS* NEW ONLINE SURVEY FOR BREAST CANCER PATIENTS NOW LIVE HOW DID THE COVID-19 PANDEMIC IMPACT BREAST CANCER PATIENTS? Open to adults diagnosed with Breast Cancer anywhere in the world. SURVEY LINK: https://t.co/7IyYPZ3USt
1
37
30
@AC_Hamilton1
Ashleigh Russell
2 years
Honoured to write an Editorial for BMJ Oncology on a new study investigating early-onset cancers. The epidemiology of early-onset cancers is changing globally and urgent research on aetiology is needed. @HelenColemanQUB @CPH_QUB @QUB_CATP
@bmj_company
BMJ Group
2 years
Global surge in cancers among the under 50s over past three decades, finds research published today in the open access journal @BMJOncology https://t.co/NRt1IAaopE https://t.co/EkOmW5fQiu
0
5
22
@AC_Hamilton1
Ashleigh Russell
2 years
What a fabulous day at PhD graduation @QUBelfast delighted to have worked with @HelenColemanQUB the best supervisor I could have asked for, and also gained a friend in the process. Looking forward to continuing my academic career in @CPH_QUB
@HelenColemanQUB
Prof Helen Coleman
2 years
What a day @QUBelfast & esp for our research on early-onset bowel cancer!! celebrating the graduation of @AC_Hamilton1 whose PhD @CPH_QUB investigated molecular epi of EOCRC, audit of treatment in NI & qualitative research with EOCRC patients on their treatment experience 👏
11
2
47
@AC_Hamilton1
Ashleigh Russell
2 years
The lay summary of our study on early onset colorectal (EOCRC) cancer is now available. Key findings: - there is a lack of recognition for EOCRC patients. - Areas of unmet need include information needs, mental health, sexual health and fertility counselling. Paper coming soon.
0
6
15
@AC_Hamilton1
Ashleigh Russell
2 years
Superb day at the Clinical Academics in Training Annual Conference 2023. Meeting and learning from clinical academics from many disciplines, sharing research and discussing future proofing healthcare research @acmedsci #CATAC2023
1
5
24
@NICanReg
NI Cancer Registry
2 years
Delighted to announce the launch of Pancreatic Audit, Sinead Hawkins NICR, funded by @NIPANC_ Full report can be found here
0
3
3
@AC_Hamilton1
Ashleigh Russell
3 years
The final version of our paper on the molecular profile of sporadic early onset colorectal cancer is now online. Our results show differences in somatic features across age groups, particularly in regard to BRAF MT https://t.co/FTL3WmmktH @HelenColemanQUB @mauriceloughrey
0
4
9
@HelenColemanQUB
Prof Helen Coleman
3 years
*New paper alert* from PhD research of Dr @AC_Hamilton1 in brand new @AmerGastroAssn journal Gastro Hep Advances. Systematic review of molecular profile in sporadic early-onset colorectal cancer Key findings: Minimal BRAF MT 1 in 10 have MSI-H/dMMR https://t.co/xvXeRDGYWz
Tweet card summary image
ghadvances.org
The observed increase in the incidence of early-onset colorectal cancer (EOCRC) is being driven by sporadic cases, but the molecular characteristics of these tumors are not fully understood. Our...
2
5
24
@AC_Hamilton1
Ashleigh Russell
3 years
Exciting results from the NICHE-2 trial investigating the use of neoadjuvant immunotherapy in dMMR colon cancer
@myESMO
ESMO - Eur. Oncology
3 years
At #ESMO22: impressive results from the NICHE-2 trial may open a way to a ‘watch and wait’ approach for patients with #dMMR #ColonCancer 👉 https://t.co/pOw6uUONxO @JenSeligmann @MyriamChalabi
0
0
5
@myESMO
ESMO - Eur. Oncology
3 years
Presidential Symposium data at #ESMO22 show air pollution drive interleukin-1β release in cells with EGFR mutations to promote #LungCancer development in non-smokers 👉 https://t.co/KUOT5qmMj3 #LCSM @TonyMok9 @CharlesSwanton
0
24
51
@AC_Hamilton1
Ashleigh Russell
3 years
Our review paper on early onset cancers is now published. We discuss the increasing incidence of malignancies in adults aged 18 to 49, summarise issues unique to this age group and discuss future research directions https://t.co/VlbAJgIQzl @HelenColemanQUB @MDPIOpenAccess
0
5
25
@AC_Hamilton1
Ashleigh Russell
3 years
Delighted to have @RyanLangdon19 @alicerosecarter and @EpiHazelwood joining us this week @CPH_QUB to share their expert knowledge of Mendelian randomisation and build collaborations for the future
0
0
9
@AC_Hamilton1
Ashleigh Russell
4 years
Last call for recruitment for our study looking at the impact of colorectal cancer treatment on adults aged under 50, closing at the end of December. Thanks to all involved so far. @HelenColemanQUB @DrHelenReid @OlindaSantin @CPH_QUB @QUBBowelCancer @QUBBowelCancer @QUB_CATP
0
2
0